Get key insights on Arvinas’ Q3 2025 earnings: clinical pipeline progress, cost controls, share buybacks, and upcoming catalysts.

Gas power M&A valuations have doubled since 2024, but new generation remains a risky investment, analysts say.

Arvinas Holding Company (($ARVN)) has held its Q3 earnings call. Read on for the main highlights of the call. Arvinas Holding Company recently ...

This story was originally published by Grist with the headline In New York, a pipeline proposal that just won’t die on Oct 28 ...

Telmex received ICREA Level VI certification for its data centers and plans to build a new one in northwest Mexico, while Telconet obtained Tier IV ...

Curious whether Axsome Therapeutics is truly a hidden gem or just riding biotech buzz? You are not alone; plenty of investors are wondering if the current price really offers value. The stock has ...

See how NOAA and U.S. Air Force “hurricane hunters” fly directly into powerful storms to collect critical weather data.

Thomas says IBM is trying to break that pattern by embracing a “build a little, test a little, learn a lot” mentality, which ...

The owner of a haunted house in Pennsylvania has a new idea to spook his patrons: the eerie whirring of fans, the humming of ...

Ventyx Biosciences, Inc. surged after strong Phase 2 results for VTX3232 in obesity. Click for key insights and what VTYX ...

Goodman Group expects its work-in-progress pipeline to hit a record AU$17.5 billion (US$11.3bn) next year, driven by the ...

Across the country, career and technical education is reshaping ideas of what high school should be, and momentum continues ...